Baco Pharm LLP - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN ABA-4896 Incorporated 03 February 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Pending Strike Off Limited Liability Partnership chemicals
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
4 yrs
Est. 2022
Designated partners
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date
LLP status
Under Process of Striking Off
MCA master data
Registrar
Mumbai
ROC office
Incorporated
03 Feb 2022
Date of incorporation
Entity type
LLP
As registered with MCA

About Baco Pharm LLP

Data last updated:

Baco Pharm LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. The LLP is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the LLP may be struck off soon. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 03 February 2022.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ABA-4896.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners including Kashiprasad Chiranjilal Murarka and Anil Kashiprasad Murarka.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

Company details

LLPIN ABA-4896
Incorporation Date 03 February 2022
Total Obligation of Contribution β‚Ή1 Lakh
ROC Mumbai
Company Status Under Process of Striking Off
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2024

Contact details

Baco Pharm LLP's registered office is in Mumbai, Maharashtra.

  • Registered Address
    B/310 Virwani Industrial Estate Off. Western Express Highway Goregaon (, East), Mumbai, Maharashtra, India – 400063
  • Industry
    Chemicals, Chemicals and Chemical Products, Manufacturing
Comprehensive company report
Baco Pharm LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Financials of Baco Pharm LLP

FY 2024 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Baco Pharm LLP, buy the company report.

Designated partners of Baco Pharm LLP

Baco Pharm has 3 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Kashiprasad Chiranjilal MurarkaDesignated Partner03 Feb 20224 Years 9 MonthsCurrent
Anil Kashiprasad MurarkaDesignated Partner03 Feb 20224 Years 9 MonthsCurrent
Sangeeta Anil MurarkaPartner03 Feb 20224 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Baco Pharm LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Baco Pharm LLP; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Baco Pharm LLP has 3 designated partner changes on record since 2022: 3 appointments. The latest: Anil Kashiprasad Murarka was appointed as Designated Partner on 03 Feb 2022.

AGM
Baco Pharm Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Baco Pharm Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Anil Kashiprasad Murarka was appointed as Designated Partner.
Appointed
Kashiprasad Chiranjilal Murarka was appointed as Designated Partner.
Appointed
Sangeeta Anil Murarka was appointed as Partner.
Incorporation
03 Feb 2022
Baco Pharm Llp was registered on 03 Feb 2022 with Roc Mumbai & aged 4 years 9 months as per MCA records.

Frequently asked questions

Baco Pharm is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the LLP from the register, typically due to non-filing of statutory returns. This process is not yet final, but the LLP may be struck off soon. Caution is advised before entering into any agreements with this entity.

Baco Pharm is a company pending strike off, currently registered as a limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 03 February 2022 and is registered under LLPIN ABA-4896. The LLP may be struck off soon - caution is advised.

Baco Pharm has 3 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Baco Pharm is ABA-4896. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Baco Pharm was incorporated on 03 February 2022. It is registered with the Registrar of Companies, Mumbai.

The registered office of Baco Pharm is at B310 Virwani Industrial Estate Off. Western Express Highway Goregaon , East, Mumbai, Maharashtra, India – 400063.

The latest financial statements of Baco Pharm on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.

Baco Pharm operates in the chemicals industry, in the chemicals and chemical products segment.

Anil Kashiprasad Murarka was appointed as Designated Partner on 03 Feb 2022. Kashiprasad Chiranjilal Murarka was appointed as Designated Partner on 03 Feb 2022. Sangeeta Anil Murarka was appointed as Partner on 03 Feb 2022.

Baco Pharm can be reached at its registered office: B310 Virwani Industrial Estate Off. Western Express Highway Goregaon , East, Mumbai, Maharashtra, India – 400063.